Ultrastructural cutaneous microvascular pathology of young adults aged up to 50 years with chronic kidney disease and vascular cognitive impairment

Ultrastructural Pathology

Volumn 34, Issue 4, 2010, Pages 214-218

  Arismendi Morillo, Gabriel ^a   Fernndez Abreu, Mary ^b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

chronic kidney disease; cognitive impairment; dementia; leukoaraiosis; small vessel disease

Indexed keywords

ADULT; ARTICLE; BRAIN; CHRONIC KIDNEY FAILURE; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; METHODOLOGY; MICROVASCULATURE; MIDDLE AGED; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULARIZATION; COMPLICATION; PROCEDURES;

ADULT; BRAIN; COGNITION DISORDERS; DEMENTIA, VASCULAR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVESSELS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SKIN;

EID: 77954331246     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913121003743690     Document Type: Article

References (19)

1. Jassal SV, Devins GM, Chan CT, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int. 2006;70:956-962.
2. Kurella M, Mapes DL, Port FK, et al. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2006;21: 2543-2548.
3. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16:3127-3133.
4. Kurella-Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the REGARDS (Reasons for Gegraphic and Racial Differences in Stroke) study. Am J Kidney Dis. 2008;52:227-234.
5. Elias MF, Elias PK, Seliger SL, et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24:2446-2452.
6. Seliger SL, Gillen DL, Longstreth WT, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603-609.
7. Royal DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 2006;64:588-594.
8. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-1322.
9. Furuta A, Ishii N, Nishibara Y, et al. Medullary arteries in aging and dementia. Stroke. 1991;22:442-446.
10. Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
11. Ringelstein E, Nabavi DG. Cerebral small vessel disease: cerebral microangiopathies. Curr Opin Neurol. 2005;18:179-188.
12. Uspenskaia O, Liebertrau M, Herms J, et al. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci. 2004;5:37 doi:10.1186/1471-2202-5-37.
13. Integan HD, Deng LY, Li JS, et al. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension. 1999;33:569-574.
14. Flamant M, Placier S, Dubroca C, et al. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension. 2007;50:212. doi:10.1161/HYPERTENSIONAHA. 107.089631.
15. Tsilibary EC. Microvascular bassement membrane in diabetes mellitus. J Pathol. 2003;200:537-546.
16. Liebetrau M, Burggraf D, Büscher C, et al. Ramipril prevents extracellular matrix accumulation in cerebral microvessels. Neurol Res. 2005;27:477-482.
17. Rizzoni D, Porteri E, De Ciuceis C, et al. Effect of treatment with Candesartan or Enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension. 2005;45:659-665.
18. Tsukuda K, Mogi M, Li JM, et al. Amelioration of cognitive impairment in the type 2 diabetic mouse by the angiotensin II type 1 receptor blocker candesartan. Hypertension. 2007;50:1099-1105.
19. Seliger SL, Longstreth WT. Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke. 2008;39:5-6.